Akèy › Twoub san
Etid klinik pou Twoub san ap rekrite nan Etazini
33 etid pou Twoub san ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Boston, MA10 etid
- Atlanta, GA10 etid
- Los Angeles, CA9 etid
- Houston, TX9 etid
- The Bronx, NY8 etid
- Nashville, TN7 etid
- New York City, NY7 etid
- Mountain View, CA6 etid
- Durham, NC5 etid
- Washington, DC5 etid
- Seattle, WA5 etid
- Greenville, NC5 etid
- Portland, OR5 etid
- Birmingham, AL4 etid
- Philadelphia, PA4 etid
- Milwaukee, WI4 etid
- San Diego, CA4 etid
- Tampa, FL4 etid
- Baldwin Park, CA3 etid
- Baltimore, MD3 etid
- Buffalo, NY3 etid
- Columbus, OH3 etid
- Cleveland, OH3 etid
- Cedar Rapids, IA3 etid
- Norfolk, VA3 etid
- Louisville, KY3 etid
- Kansas City, MO3 etid
- Indianapolis, IN3 etid
- Phoenix, AZ3 etid
- Miami, FL3 etid
- Clifton, NJ3 etid
Pa eta
- Alabama5 etid
- Arizona3 etid
- Arkansas3 etid
- Distrik Columbia4 etid
- Florid9 etid
- Georgia11 etid
- Indiana3 etid
- Iowa3 etid
- Kalifòni16 etid
- Kentucky4 etid
- Maryland5 etid
- Massachusetts10 etid
- Minnesota3 etid
- Missouri4 etid
- New Jersey5 etid
- New York12 etid
- North Carolina9 etid
- Ohio6 etid
- Oregon5 etid
- Pennsylvania4 etid
- Tennessee7 etid
- Texas10 etid
- Virginia5 etid
- Washington6 etid
- Wisconsin4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Ap rekriteFaz 3
Laj 12 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT06439082Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06910969Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Ap rekriteFaz 3
Laj 18 a 71 · Tout sèks · Mizajou Sep 23, 2026 · NCT07504458Treatment of Hemophilia A Patients With FVIII Inhibitors
Ap rekriteEtid obsèvasyon
Tout laj · Gason · Mizajou Sep 23, 2026 · NCT04023019A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06722235(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04996875A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 11, 2026 · NCT07059000A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06948318Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07601425A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07075185ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 17, 2026 · NCT04398628A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05254743Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07216443Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
Ap rekrite
Jiska laj 55 · Tout sèks · Mizajou Jul 6, 2026 · NCT01666080Therapeutic RSK1 Targeting in Myelofibrosis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT07379125A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT04256317ATHNdataset Registry
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Apr 21, 2026 · NCT06820515Diamond Blackfan Anemia Registry (DBAR)
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Apr 16, 2026 · NCT00106015Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Apr 16, 2026 · NCT06828796Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 ak plis · Tout sèks · Mizajou Apr 2, 2026 · NCT03207854Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Ap rekriteFaz 3
Laj 12 a 35 · Tout sèks · Mizajou Mar 23, 2026 · NCT05477563Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback
Ap rekriteFaz 1
1 Month – 45 Years · Tout sèks · Mizajou Jan 8, 2026 · NCT04640987Hematology Biobank: In Vitro Study of Blood Disorders
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Jan 6, 2026 · NCT02442011CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
Ap rekriteFaz 1
3 Months – 30 Years · Tout sèks · Mizajou Nov 28, 2025 · NCT06559189BMT-CARE: Psychosocial Intervention for Transplant Caregivers
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 15, 2025 · NCT06472089Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.